Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Zimmermann

Showing results (91-100 of 424) with videos related to

Pageof 43
Sort By:
Regulatory Toxicology and Pharmacology : RTP|November 23, 2018
In further defense of nonclinical abuse liability testing of biologicsDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
Biological Chemistry|March 18, 2000
Activation of progelatinase B by membranes of human polymorphonuclear granulocytesH Kolkenbrock, J Zimmermann, G R Burmester, et al.
Journal of Pharmacological and Toxicological Methods|March 20, 2017
Method of data interpretation for the determination of abuse liability in rodent self-administration studies under the FDA guidance documentDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
Medical Physics|March 8, 2013
Gantry and isocenter displacements of a linear accelerator caused by an add-on micromultileaf collimatorHans L Riis, Sune J Zimmermann, Mogens Hjelm-Hansen
Biological Chemistry|December 25, 2009
Principles, implementation, and application of biology-oriented synthesis (BIOS)Wolfram Wilk, Tobias J Zimmermann, Markus Kaiser, et al.
Regulatory Toxicology and Pharmacology : RTP|January 12, 2022
De-risking in Tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observersDavid V Gauvin, Zachary J Zimmermann, Jill A Dalton
World Journal of Urology|November 8, 2005
Influence of a high-oxalate diet on intestinal oxalate absorptionDiana J Zimmermann, Albrecht Hesse, Gerd E von Unruh
Regulatory Toxicology and Pharmacology : RTP|June 25, 2015
Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policiesDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
Journal of Pharmacological and Toxicological Methods|August 21, 2018
The gold-standard in preclinical abuse liability testing: It's all relativeDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
American Journal of Surgery|December 1, 1976
The surgical management of reflux gastritisG J Zimmermann, K C Westbrook, B W Thompson
Pageof 43

Showing results (91-100 of 424) with videos related to

Sort By:
Pageof 43
Regulatory Toxicology and Pharmacology : RTP|November 23, 2018
In further defense of nonclinical abuse liability testing of biologicsDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
Biological Chemistry|March 18, 2000
Activation of progelatinase B by membranes of human polymorphonuclear granulocytesH Kolkenbrock, J Zimmermann, G R Burmester, et al.
Journal of Pharmacological and Toxicological Methods|March 20, 2017
Method of data interpretation for the determination of abuse liability in rodent self-administration studies under the FDA guidance documentDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
Medical Physics|March 8, 2013
Gantry and isocenter displacements of a linear accelerator caused by an add-on micromultileaf collimatorHans L Riis, Sune J Zimmermann, Mogens Hjelm-Hansen
Biological Chemistry|December 25, 2009
Principles, implementation, and application of biology-oriented synthesis (BIOS)Wolfram Wilk, Tobias J Zimmermann, Markus Kaiser, et al.
Regulatory Toxicology and Pharmacology : RTP|January 12, 2022
De-risking in Tier I CNS safety assessments is the primary function of study design and technical training of laboratory staff observersDavid V Gauvin, Zachary J Zimmermann, Jill A Dalton
World Journal of Urology|November 8, 2005
Influence of a high-oxalate diet on intestinal oxalate absorptionDiana J Zimmermann, Albrecht Hesse, Gerd E von Unruh
Regulatory Toxicology and Pharmacology : RTP|June 25, 2015
Preclinical assessment of abuse liability of biologics: In defense of current regulatory control policiesDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
Journal of Pharmacological and Toxicological Methods|August 21, 2018
The gold-standard in preclinical abuse liability testing: It's all relativeDavid V Gauvin, Zachary J Zimmermann, Theodore J Baird
American Journal of Surgery|December 1, 1976
The surgical management of reflux gastritisG J Zimmermann, K C Westbrook, B W Thompson
Pageof 43